Effects of Laminaria japonica polysaccharides on airway inflammation of lungs in an asthma mouse model

Multidisciplinary Respiratory Medicine

Volumn 10, Issue 1, 2015, Pages

  Lin, Rongjun ^a   Liu, Xiaomei ^a   Meng, Yan ^b   Xu, Mei ^c   Guo, Jianping ^d  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b Department of Pediatrics People's Hospital of Zoucheng City   (China)

^c Department of Pediatrics People's Hospital of Central District   (China)

^d Center of Hospital of Women and Children of Qingdao City   (China)

Author keywords

Allergy; Asthma; Immunomodulation; Inflammation; Sulfated polysaccharides

Indexed keywords

BUDESONIDE; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 13; LAMINARIA JAPONICA EXTRACT; PLANT EXTRACT; POLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIASTHMATIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG ACTIVITY; EOSINOPHIL COUNT; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG INFILTRATE; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION;

EID: 84935038533     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/s40248-015-0017-0     Document Type: Article

References (30)

1. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22:789-815. doi: 10.1146/annurev.immunol.22.012703.104716.
2. Girodet PO, Ozier A, Bara I, de Tunon Lara JM, Marthan R, Berger P. Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention. Pharmacol Ther. 2011;130(3):325-37. doi: 10.1016/j.pharmthera.2011.02.001.
3. Aun MV, Ribeiro MR, Costa Garcia CL, Agondi RC, Kalil J, Giavina-Bianchi P. Esophageal candidiasis-an adverse effect of inhaled corticosteroids therapy. J Asthma. 2009;46(4):399-401. doi: 10.1080/02770900902777783.
4. Visser MJ, van der Veer E, Postma DS, Arends LR, de Vries TW, Brand PL, et al. Side-effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J. 2004;24(3):420-5. doi: 10.1183/09031936.04.00023904.
5. Li X, Yu Z, Long S, Guo Y, Duan D. Hypoglycemic Effect of Laminaria japonica Polysaccharide in a Type 2 Diabetes Mellitus Mouse Model. ISRN Endocrinol. 2012;2012:507462. doi: 10.5402/2012/507462.
6. Zeng F, Zhao C, Pang J, Lin Z, Huang Y, Liu B. Chemical properties of a polysaccharide purified from solid-state fermentation of auricularia auricular and its biological activity as a hypolipidemic agent. J Food Sci. 2013;78(9):H1470-5. doi: 10.1111/1750-3841.12226.
7. Zhai Q, Li X, Yang Y, Yu L, Yao Y. Antitumor activity of a polysaccharide fraction from Laminaria japonica on U14 cervical carcinoma-bearing mice. Tumour Biol. 2014;35(1):117-22. doi: 10.1007/s13277-013-1014-6.
8. Locke NR, Royce SG, Wainewright JS, Samuel CS, Tang ML. Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease. Am J Respir Cell Mol Biol. 2007;36(5):625-32. doi: 10.1165/rcmb.2006-0083OC.
9. Myers SP, O'Connor J, Fitton JH, Brooks L, Rolfe M, Connellan P, et al. A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis. Biologics. 2010;4:33-44.
10. Myers SP, O'Connor J, Fitton JH, Brooks L, Rolfe M, Connellan P, et al. A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex. Biologics. 2011;5:45-60. doi: 10.2147/BTT.S12535.
11. Taube C, Duez C, Cui ZH, Takeda K, Rha YH, Park JW, et al. The role of IL-13 in established allergic airway disease. J Immunol. 2002;169(11):6482-9.
12. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282(5397):2258-61.
13. Gauvreau GM, Boulet LP, Cockcroft DW, Fitzgerald JM, Carlsten C, Davis BE, et al. Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med. 2011;183(8):1007-14. doi: 10.1164/rccm.201008-1210OC.
14. Newcomb DC, Boswell MG, Huckabee MM, Goleniewska K, Dulek DE, Reiss S, et al. IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner. J Immunol. 2012;188(3):1027-35. doi: 10.4049/jimmunol.1102216.
15. Kips JC, Brusselle GJ, Joos GF, Peleman RA, Tavernier JH, Devos RR, et al. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med. 1996;153(2):535-9. doi: 10.1164/ajrccm.153.2.8564093.
16. Lee YL, Fu CL, Ye YL, Chiang BL. Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation. Scand J Immunol. 1999;49(3):229-36.
17. Naseer T, Minshall EM, Leung DY, Laberge S, Ernst P, Martin RJ, et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med. 1997;155(3):845-51. doi: 10.1164/ajrccm.155.3.9117015.
18. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med. 1993;177(4):1199-204.
19. Boxall C, Holgate ST, Davies DE. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J. 2006;27(1):208-29. doi: 10.1183/09031936.06.00130004.
20. Hackett TL, Warner SM, Stefanowicz D, Shaheen F, Pechkovsky DV, Murray LA, et al. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. Am J Respir Crit Care Med. 2009;180(2):122-33. doi: 10.1164/rccm.200811-1730OC.
21. Chi XY, Jiang SJ, Wang J, Wang JP. Effect of glucocorticoid in mice of asthma induced by ovalbumin sensitisation and RSV infection. Asian Pac J Allergy Immunol. 2011;29(2):176-80.
22. Mirzamani MS, Nourani MR, Imani Fooladi AA, Zare S, Ebrahimi M, Yazdani S, et al. Increased expression of transforming growth factor-beta and receptors in primary human airway fibroblasts from chemical inhalation patients. Iran J Allergy Asthma Immunol. 2013;12(2):144-52.
23. Cho JY, Miller M, Baek KJ, Han JW, Nayar J, Lee SY, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest. 2004;113(4):551-60. doi: 10.1172/JCI19133.
24. Yum HY, Cho JY, Miller M, Broide DH. Allergen-induced coexpression of bFGF and TGF-beta1 by macrophages in a mouse model of airway remodeling: bFGF induces macrophage TGF-beta1 expression in vitro. Int Arch Allergy Immunol. 2011;155(1):12-22. doi: 10.1159/000317213.
25. Scherf W, Burdach S, Hansen G. Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model. Eur J Immunol. 2005;35(1):198-206. doi: 10.1002/eji.200425209.
26. Xiong YY, Wang JS, Wu FH, Li J, Kong LY. The effects of (+/-)-Praeruptorin A on airway inflammation, remodeling and transforming growth factor-beta1/Smad signaling pathway in a murine model of allergic asthma. Int Immunopharmacol. 2012;14(4):392-400. doi: 10.1016/j.intimp.2012.08.019.
27. Makarenkova ID, Logunov DY, Tukhvatulin AI, Semenova IB, Besednova NN, Zvyagintseva TN. Interactions between sulfated polysaccharides from sea brown algae and Toll-like receptors on HEK293 eukaryotic cells in vitro. Bull Exp Biol Med. 2012;154(2):241-4.
28. Yang M, Ma C, Sun J, Shao Q, Gao W, Zhang Y, et al. Fucoidan stimulation induces a functional maturation of human monocyte-derived dendritic cells. Int Immunopharmacol. 2008;8(13-14):1754-60. doi: 10.1016/j.intimp.2008.08.007.
29. Kim MH, Joo HG. Immunostimulatory effects of fucoidan on bone marrow-derived dendritic cells. Immunol Lett. 2008;115(2):138-43. doi: 10.1016/j.imlet.2007.10.016.
30. Maruyama H, Tamauchi H, Iizuka M, Nakano T. The role of NK cells in antitumor activity of dietary fucoidan from Undaria pinnatifida sporophylls (Mekabu). Planta Med. 2006;72(15):1415-7. doi: 10.1055/s-2006-951703.